Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-center, Randomized, Double-blind Controlled Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation

NCT07342205 is registered in ClinicalTrials.gov with Shanghai University of Traditional Chinese Medicine as lead sponsor.

NCT NCT07342205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07342205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-center, Randomized, Double-blind Controlled Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation
Lead sponsor
Shanghai University of Traditional Chinese Medicine
Phase
Phase 2/3
Overall status
Recruiting
Start date
December 10, 2025
Completion date
June 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lung injury(ali), acute respiratory distress syndrome (ards), sepsis related acute lung injury/acute respiratory distress syndrome